Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

therapy

therapy is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 523
News articles 0
Drug details — therapy
Class
—
Route
—
Patents
20
Programs
523
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

therapy is an FDA-listed pharmaceutical active ingredient.

Key facts

INN therapy

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 10-week smoking cessation group therapy combined with NicoDerm CQ Phase 3 · BRIGHT MINDS BIOSCIENCES · Tobacco Use Cessation
  2. 2 cycles induction chemotherapy Phase 3 · First People's Hospital · Locally Advanced Nasopharyngeal Carcinoma
  3. 2008-46 Phase 3 · First People's Hospital · Colorectal Neoplasms
  4. 20170770 Phase 3 · Amgen · Chemotherapy-induced Thrombocytopenia in Adult subjects with
  5. 20230127 Phase 3 · Amgen · Early-stage Non-squamous Non-small Cell Lung Cancer
  6. 217102 Phase 3 · GSK Glaxo Smith · Relapsing or refractory Eosinophilic Granulomatosis with Pol
  7. 2215-CL-0201 Phase 3 · Astellas Pharma · Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in
  8. 3-dimensional conformal radiation therapy Phase 3 · United Therapeutics Europe · Head and Neck Cancer

Related patents

Browse patents

  1. US 12420113

    Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12414983

    CD200AR ligands for cancer immunotherapy

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12404318

    Combination HBV therapy

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12397028

    Adoptive cellular therapy

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12397066

    Delivery of gene therapy treatments

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12384830

    Compositions and methods for improving immunotherapy

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12385010

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12377093

    Pyruvate kinase activators for use in therapy

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. CN 120418289

    Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors

    Expires Thu Jul 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12370206

    Therapy for inhibition of single-stranded RNA virus replication

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12364765

    Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12364774

    Nucleic acid molecules and uses thereof for non-viral gene therapy

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12364775

    Viral vectors for cancer therapy

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12359204

    Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12350318

    Combination therapy to treat brain cancer

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12336976

    Glutaminase inhibitor therapy

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12338459

    DNA-chimeric antigen receptor T cells for immunotherapy

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12338450

    Gene therapy constructs for treating Wilson disease

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12337017

    Microbiota transfer therapy for Pitt Hopkins Syndrome

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12329816

    Immunotherapy with metabolic enzyme expression

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is therapy?

therapy is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.